Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,948 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Australian Aboriginal and Torres Strait Islander people at risk of declining mental health due to failure to attend for referred follow-up mental health appointments during COVID-19.
Usher K, Jackson D, Peng W, Amarasena S, Porter C, McCowan D, Miller J, Peake R, Sibbritt D. Usher K, et al. Among authors: porter c. Int J Ment Health Nurs. 2022 Dec;31(6):1279-1281. doi: 10.1111/inm.13060. Epub 2022 Sep 7. Int J Ment Health Nurs. 2022. PMID: 36070004 Free PMC article. No abstract available.
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesin.
Berndsen ZT, Akhtar M, Thapa M, Vickers T, Schmitz A, Torres JL, Baboo S, Kumar P, Khatoom N, Sheikh A, Hamrick M, Diedrich JK, Martinez-Bartolome S, Garrett PT, Yates JR, Turner JS, Laird RM, Poly F, Porter CK, Copps J, Ellebedy AH, Ward AB, Fleckenstein JM. Berndsen ZT, et al. Among authors: porter ck. bioRxiv [Preprint]. 2024 May 8:2024.05.08.593125. doi: 10.1101/2024.05.08.593125. bioRxiv. 2024. PMID: 38766097 Free PMC article. Preprint.
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.
Murphy AD, Porter C, White A, Irving A, Adams R, Ray R, Casbard A, Mahmood RD, Karanth S, Zhou C, Pugh J, Wheeler C, Roberts V, Arnetoli G, Salih Z, Hasan J, Mitchell C, Morgan RD, Clamp AR, Jayson GC. Murphy AD, et al. Among authors: porter c. Int J Gynecol Cancer. 2024 May 9:ijgc-2024-005455. doi: 10.1136/ijgc-2024-005455. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38724236
Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic E. coli Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701).
Talaat KR, Porter CK, Chakraborty S, Feijoo BL, Brubaker J, Adjoodani BM, DeNearing B, Prouty MG, Poole ST, Bourgeois AL, Billingsley M, Sack DA, Eder-Lingelbach S, Taucher C. Talaat KR, et al. Among authors: porter ck. Microorganisms. 2024 Apr 3;12(4):727. doi: 10.3390/microorganisms12040727. Microorganisms. 2024. PMID: 38674674 Free PMC article.
E-Consults in Dermatology: A Retrospective Analysis.
Salisbury KR, Porter CL, Ali AK, Strowd LC. Salisbury KR, et al. Among authors: porter cl. Cutis. 2024 Mar;113(3):107-109. doi: 10.12788/cutis.0975. Cutis. 2024. PMID: 38648591
1,948 results